Ayala Pharmaceuticals Inc (NASDAQ:AYLA)
| 1.37 Delayed Data As of 2:11pm ET |  +0.01 / +0.74%Today’s Change | 0.70 Today|||52-Week Range 14.95 | -83.90% Year-to-Date |
Latest AYLA News | Press Releases
| ProPhase Labs, Inc. (PRPH) Tops Q2 Earnings and Revenue Estimates Aug 11 / Zacks.com - Paid Partner Content | PTC Therapeutics (PTCT) Reports Q2 Loss, Tops Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content |
| Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue Estimates Aug 09 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.36 |
| Today’s open | 1.32 |
| Day’s range | 1.32 - 1.38 |
| Volume | 1,328 |
| Average volume (3 months) | 1,619,425 |
| Market cap | $22.7M |
Data as of 2:11pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | +8.56% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -5.45% |
| P/E ratio | NM |
| Price/Sales | 34.95 |
| Price/Book | 0.66 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 18, 2022 |
| EPS forecast (this quarter) | -$0.65 |
| Annual revenue (last year) | $3.5M |
| Annual profit (last year) | -$40.3M |
| Net profit margin | -1,148.15% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
